OWP
ADMA icon

Old Well Partners’s ADMA Biologics ADMA Stock Holding History

Old Well Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,537
Closed -$56K – 43
2020
Q3 		$56K Buy
23,537
+1,445
+7% +$3.96K 0.05% 36
2020
Q2 		$65K Hold
22,092
– – 0.05% 26
2020
Q1 		$64K Buy
22,092
+6,975
+46% +$24.1K 0.06% 27
2019
Q4 		$60K Buy
+15,117
New +$65.9K 0.05% 29

Other funds holding ADMA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Old Well Partners's ADMA Position: Q4 2020 in Review

Old Well Partners sold out of ADMA Biologics (ADMA) in Q4 2020, closing a stake of 23,537 shares — an estimated $56K sold.

Old Well Partners first reported a position in ADMA in Q4 2019 and held it in 4 quarters. The position peaked at $65K in Q2 2020. 95 funds tracked by Wall St. Rank hold ADMA as of Q4 2020.

  • Old Well Partners reported no remaining ADMA Biologics position as of Q4 2020 after selling out during the quarter.
  • Old Well Partners sold 23,537 ADMA Biologics shares in Q4 2020, an estimated $56K.
  • Old Well Partners first reported a position in ADMA Biologics in Q4 2019 and held it in 4 quarters.
  • Old Well Partners's ADMA Biologics position peaked at $65K in Q2 2020.
  • 95 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2020.

Based on Old Well Partners's 13F filing for Q4 2020, filed 16 Feb 2021.